수의 분자진단 시장

Global Veterinary Molecular Diagnostics Market to Reach US$2.8 Billion by 2032

The global market for Veterinary Molecular Diagnostics estimated at US$1.5 Billion in the year 2025, is expected to reach US$2.8 Billion by 2032, growing at a CAGR of 9.9% over the analysis period 2025-2032. Instruments Offering, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Test Kits & Reagents Offering segment is estimated at 11.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$394.6 Million While China is Forecast to Grow at 13.4% CAGR

The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$394.6 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$610.4 Million by the year 2032 trailing a CAGR of 13.4% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Veterinary Molecular Diagnostics Market - Key Trends & Growth Drivers Explored

Why Are Veterinary Molecular Diagnostics Revolutionizing Animal Health Management?

Veterinary molecular diagnostics have emerged as a transformative tool in animal healthcare, enabling precise and rapid detection of diseases at the molecular level. But what makes these diagnostic methods so essential in modern veterinary practices? Veterinary molecular diagnostics are advanced testing techniques that identify genetic material, such as DNA and RNA, from pathogens, tumors, or genetic disorders in animals. These tests include polymerase chain reaction (PCR), real-time PCR, next-generation sequencing (NGS), and microarrays, among others, which can detect and quantify pathogens, genetic mutations, or biomarkers with high sensitivity and specificity. By targeting the genetic basis of diseases, these diagnostics allow veterinarians to diagnose conditions early, often before clinical symptoms appear, providing a crucial window for timely intervention and treatment.

The demand for veterinary molecular diagnostics is driven by the growing prevalence of zoonotic diseases, the rising incidence of chronic and infectious conditions in animals, and the increasing focus on preventive healthcare. These diagnostics are widely used in the detection of infectious diseases such as parvovirus, feline leukemia, and bovine respiratory disease, as well as for genetic screening in breeding programs to prevent the transmission of hereditary disorders. Molecular diagnostics have also become indispensable in the field of oncology, where they are used to identify specific mutations and biomarkers that can guide targeted therapies for cancer treatment. Furthermore, the ability to differentiate between closely related pathogens and detect multiple pathogens in a single test has made molecular diagnostics a preferred choice in complex cases where traditional testing methods may fall short. As pet owners, livestock managers, and veterinarians seek more accurate and reliable diagnostic solutions, veterinary molecular diagnostics are poised to play an increasingly central role in animal health management.

How Are Technological Advancements Elevating the Performance of Veterinary Molecular Diagnostics?

The veterinary molecular diagnostics market has experienced significant technological advancements that have enhanced the precision, speed, and accessibility of these diagnostic tools. But what are the key innovations driving these developments? One of the most impactful advancements is the evolution of real-time PCR (qPCR) technology. qPCR has become a gold standard in veterinary diagnostics due to its ability to amplify and quantify DNA or RNA sequences in real-time, providing rapid and highly sensitive results. Modern qPCR systems are equipped with multiplexing capabilities, allowing the simultaneous detection of multiple pathogens or genetic markers in a single sample. This innovation has significantly reduced turnaround times and the need for multiple tests, enabling veterinarians to make quicker and more informed decisions. Additionally, the integration of automated sample preparation systems has streamlined the workflow, reducing the potential for human error and increasing the consistency and reliability of test results.

Another critical innovation is the advent of next-generation sequencing (NGS) technology, which has revolutionized the field of veterinary genomics. NGS allows for comprehensive genetic analysis by sequencing entire genomes or targeted regions of interest, providing insights into complex genetic traits, disease mechanisms, and microbial communities. This technology is being increasingly used in research and clinical settings for applications such as pathogen discovery, antimicrobial resistance monitoring, and cancer genotyping. The development of portable and point-of-care molecular diagnostic devices has further expanded the reach of these technologies, enabling veterinarians to conduct testing on-site, whether in clinics, farms, or field settings. These devices are designed to be user-friendly, requiring minimal training and infrastructure, making advanced molecular diagnostics accessible even in remote or resource-limited environments. Furthermore, advancements in bioinformatics and data analytics have enhanced the interpretation of molecular diagnostic results, allowing for more accurate and actionable insights. These technological innovations have collectively elevated the performance and utility of veterinary molecular diagnostics, making them indispensable tools for modern veterinary medicine.

What Market Trends Are Driving the Adoption of Veterinary Molecular Diagnostics Across Animal Healthcare?

Several emerging market trends are shaping the adoption of veterinary molecular diagnostics across the animal healthcare sector, reflecting the evolving needs and expectations of veterinarians, researchers, and pet owners. One of the most prominent trends is the increasing focus on preventive care and early disease detection. As pet owners and livestock managers become more aware of the benefits of early diagnosis, there is a growing demand for diagnostic tools that can detect diseases at the subclinical stage, before they become symptomatic or spread to other animals. Veterinary molecular diagnostics, with their high sensitivity and specificity, are well-suited for this purpose, allowing for the early identification of infectious agents, genetic disorders, and cancerous cells. This trend is particularly strong in the companion animal sector, where regular health screenings and wellness programs are becoming more common. The ability to detect genetic predispositions and infectious diseases early enables veterinarians to implement targeted preventive measures and develop personalized treatment plans, improving health outcomes and reducing the long-term costs of care.

Another key trend driving the adoption of veterinary molecular diagnostics is the rising prevalence of zoonotic diseases and the need for effective disease surveillance. Zoonotic diseases, which are transmitted between animals and humans, pose a significant public health risk, making early and accurate diagnosis essential for controlling outbreaks and preventing cross-species transmission. The COVID-19 pandemic has underscored the importance of robust disease surveillance systems, leading to increased investment in diagnostic infrastructure for both companion animals and livestock. Veterinary molecular diagnostics are playing a critical role in this effort by providing tools that can detect zoonotic pathogens rapidly and accurately, supporting efforts to track and control disease spread. This trend is particularly evident in regions with large livestock populations, such as North America and Europe, where molecular diagnostics are used to monitor diseases like avian influenza, bovine tuberculosis, and African swine fever. The growing demand for comprehensive disease surveillance and biosecurity measures is expected to continue driving the adoption of molecular diagnostics in both the public and private sectors, reinforcing their role as key instruments in animal health management.

What Factors Are Driving the Growth of the Global Veterinary Molecular Diagnostics Market?

The growth in the global veterinary molecular diagnostics market is driven by several factors, including advancements in diagnostic technology, increasing investment in animal healthcare, and rising awareness of zoonotic diseases. One of the primary growth drivers is the expanding pet population and the humanization of pets, where owners treat their animals as family members and are willing to invest in advanced healthcare services. This has led to a surge in demand for diagnostic tests that provide quick and accurate results, enabling early diagnosis and effective treatment. The development of user-friendly and automated molecular diagnostic platforms has made it easier for veterinary clinics and hospitals to incorporate these tests into their routine diagnostic offerings, further boosting market growth. The increasing use of molecular diagnostics in livestock management is another key growth driver, as farmers and producers seek to improve herd health, productivity, and disease control.

Another significant growth driver is the rising incidence of infectious diseases and the growing need for effective disease management and control. Outbreaks of diseases like avian influenza, African swine fever, and canine parvovirus have highlighted the importance of rapid and accurate diagnostics for preventing disease spread and minimizing economic losses. Veterinary molecular diagnostics provide a reliable solution for detecting and differentiating pathogens, enabling veterinarians to implement timely and targeted interventions. The growing focus on antimicrobial resistance (AMR) is also contributing to market growth, as molecular diagnostics can identify resistance genes and guide the appropriate use of antibiotics, reducing the risk of resistance development. Furthermore, the expansion of veterinary diagnostic laboratories and research institutions, particularly in emerging markets such as Asia-Pacific and Latin America, is creating new opportunities for market growth. As these regions invest in modernizing their veterinary infrastructure and improving access to advanced diagnostic technologies, the global veterinary molecular diagnostics market is poised for sustained expansion, driven by a dynamic interplay of technological innovation, evolving healthcare practices, and increasing awareness of animal and public health.

SCOPE OF STUDY:

The report analyzes the Veterinary Molecular Diagnostics market by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Instruments Offering, Test Kits & Reagents Offering, Software & Services Offering); Animal Type (Companion Animal Type, Livestock Animal Type); Technology (PCR Technology, DNA Sequencing Technology, Microarrays Technology, INAAT Kits Technology); Application (Infectious Diseases Application, Metabolic Disease Application, Genetics Application, Other Applications); End-Use (Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• BIOMEDICA Medizinprodukte GmbH & Co., KG
• Bioneer Corporation
• HealthGene Corporation
• Idexx Laboratories, Inc.
• Novacyt Group
• Qiagen NV
• Thermo Fisher Scientific, Inc.
• Vca, Inc.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Veterinary Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Infectious Diseases in Companion and Livestock Animals Drives Demand for Veterinary Molecular Diagnostics
  • Increased Adoption of Molecular Diagnostic Techniques in Veterinary Clinics and Laboratories Expands Addressable Market
  • Rising Use of Molecular Diagnostics in Zoonotic Disease Surveillance Sets the Stage for Market Growth
  • Surge in Demand for Molecular Diagnostic Tests in Food Safety and Animal Health Monitoring Expands Market Opportunities
  • Growing Adoption of Molecular Diagnostics in Veterinary Oncology and Genetic Disease Testing Strengthens Business Case
  • Technological Advancements in Multiplex and High-Throughput Molecular Diagnostic Platforms Propel Market Expansion
  • Growing Use of Molecular Diagnostics in Animal Reproductive Health and Fertility Management Strengthens Market Growth
  • Surge in Use of Molecular Diagnostic Techniques in Wildlife and Conservation Medicine Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Veterinary Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 3: World Historic Review for Veterinary Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 4: World 13-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 6: World Historic Review for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 7: World 13-Year Perspective for Instruments Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 8: World Recent Past, Current & Future Analysis for Test Kits & Reagents Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 9: World Historic Review for Test Kits & Reagents Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 10: World 13-Year Perspective for Test Kits & Reagents Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 11: World Recent Past, Current & Future Analysis for Software & Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 12: World Historic Review for Software & Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 13: World 13-Year Perspective for Software & Services Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 14: World Recent Past, Current & Future Analysis for Companion Animal Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 15: World Historic Review for Companion Animal Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 16: World 13-Year Perspective for Companion Animal Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 17: World Recent Past, Current & Future Analysis for Livestock Animal Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 18: World Historic Review for Livestock Animal Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 19: World 13-Year Perspective for Livestock Animal Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 20: World Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 21: World Historic Review for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 22: World 13-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 23: World Recent Past, Current & Future Analysis for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 24: World Historic Review for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 25: World 13-Year Perspective for DNA Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 26: World Recent Past, Current & Future Analysis for Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 27: World Historic Review for Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 28: World 13-Year Perspective for Microarrays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 29: World Recent Past, Current & Future Analysis for INAAT Kits Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 30: World Historic Review for INAAT Kits Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 31: World 13-Year Perspective for INAAT Kits Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 33: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 34: World 13-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 35: World Recent Past, Current & Future Analysis for Metabolic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 36: World Historic Review for Metabolic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 37: World 13-Year Perspective for Metabolic Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 38: World Recent Past, Current & Future Analysis for Genetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 39: World Historic Review for Genetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 40: World 13-Year Perspective for Genetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 43: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 44: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 45: World Historic Review for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 46: World 13-Year Perspective for Veterinary Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 47: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 48: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 49: World 13-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 52: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 53: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 54: USA Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 55: USA 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 56: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 57: USA Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 58: USA 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 59: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 60: USA Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 61: USA 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 62: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 63: USA Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 64: USA 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 65: USA Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 66: USA Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 67: USA 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 69: Canada Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 70: Canada 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 72: Canada Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 73: Canada 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 75: Canada Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 76: Canada 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 78: Canada Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 79: Canada 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 81: Canada Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 82: Canada 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• JAPAN
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 84: Japan Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 85: Japan 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 87: Japan Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 88: Japan 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 90: Japan Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 91: Japan 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 93: Japan Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 94: Japan 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 96: Japan Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 97: Japan 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• CHINA
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 98: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 99: China Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 100: China 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 101: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 102: China Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 103: China 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 104: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 105: China Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 106: China 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 107: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 108: China Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 109: China 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 110: China Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 111: China Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 112: China 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• EUROPE
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 114: Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 115: Europe 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 117: Europe Historic Review for Veterinary Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 118: Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 120: Europe Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 121: Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 123: Europe Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 124: Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 126: Europe Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 127: Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 129: Europe Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 130: Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• FRANCE
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 131: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 132: France Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 133: France 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 134: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 135: France Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 136: France 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 137: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 138: France Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 139: France 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 140: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 141: France Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 142: France 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 143: France Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 144: France Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 145: France 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• GERMANY
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 147: Germany Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 148: Germany 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 149: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 150: Germany Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 151: Germany 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 152: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 153: Germany Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 154: Germany 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 155: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 156: Germany Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 157: Germany 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 158: Germany Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 159: Germany Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 160: Germany 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 161: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 162: Italy Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 163: Italy 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 164: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 165: Italy Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 166: Italy 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 167: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 168: Italy Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 169: Italy 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 170: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 171: Italy Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 172: Italy 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 173: Italy Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 174: Italy Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 175: Italy 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 176: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 177: UK Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 178: UK 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 179: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 180: UK Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 181: UK 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 182: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 183: UK Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 184: UK 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 185: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 186: UK Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 187: UK 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 188: UK Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 189: UK Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 190: UK 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 191: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 192: Spain Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 193: Spain 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 194: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 195: Spain Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 196: Spain 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 197: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 198: Spain Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 199: Spain 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 200: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 201: Spain Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 202: Spain 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 203: Spain Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 204: Spain Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 205: Spain 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 206: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Russia Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 208: Russia 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 209: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 210: Russia Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 211: Russia 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 212: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 213: Russia Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 214: Russia 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 215: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 216: Russia Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 217: Russia 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 218: Russia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 219: Russia Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 220: Russia 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 221: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 222: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 223: Rest of Europe 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 225: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 226: Rest of Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 228: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 229: Rest of Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 232: Rest of Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 234: Rest of Europe Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 235: Rest of Europe 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• ASIA-PACIFIC
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • TABLE 236: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 237: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 238: Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 240: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 241: Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 243: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 244: Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 246: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 247: Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 249: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 250: Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 252: Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 253: Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AUSTRALIA
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
  • TABLE 254: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 255: Australia Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 256: Australia 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 257: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 258: Australia Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 259: Australia 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 260: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 261: Australia Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 262: Australia 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 263: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 264: Australia Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 265: Australia 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 266: Australia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 267: Australia Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 268: Australia 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• INDIA
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
  • TABLE 269: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 270: India Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 271: India 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 272: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 273: India Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 274: India 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 275: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 276: India Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 277: India 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 278: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 279: India Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 280: India 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 281: India Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 282: India Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 283: India 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SOUTH KOREA
  • TABLE 284: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 285: South Korea Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 286: South Korea 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 287: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 288: South Korea Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 289: South Korea 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 290: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 291: South Korea Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 292: South Korea 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 293: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 294: South Korea Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 295: South Korea 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 296: South Korea Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 297: South Korea Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 298: South Korea 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF ASIA-PACIFIC
  • TABLE 299: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 300: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 301: Rest of Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 302: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 303: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 304: Rest of Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 306: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 307: Rest of Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 309: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 310: Rest of Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 312: Rest of Asia-Pacific Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 313: Rest of Asia-Pacific 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• LATIN AMERICA
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 314: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 315: Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 316: Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 317: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 318: Latin America Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 319: Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 320: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 321: Latin America Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 322: Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 323: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 324: Latin America Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 325: Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 326: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 327: Latin America Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 328: Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 329: Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 330: Latin America Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 331: Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 332: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 333: Argentina Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 334: Argentina 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 335: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 336: Argentina Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 337: Argentina 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 338: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 339: Argentina Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 340: Argentina 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 341: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 342: Argentina Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 343: Argentina 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 344: Argentina Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 345: Argentina Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 346: Argentina 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 347: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 348: Brazil Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 349: Brazil 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 350: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 351: Brazil Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 352: Brazil 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 353: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 354: Brazil Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 355: Brazil 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 356: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 357: Brazil Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 358: Brazil 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 359: Brazil Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 360: Brazil Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 361: Brazil 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 362: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 363: Mexico Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 364: Mexico 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 365: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 366: Mexico Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 367: Mexico 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 368: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 369: Mexico Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 370: Mexico 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 371: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 372: Mexico Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 373: Mexico 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 374: Mexico Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 375: Mexico Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 376: Mexico 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 377: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 378: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 379: Rest of Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 380: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 381: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 382: Rest of Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 384: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 385: Rest of Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 387: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 388: Rest of Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 390: Rest of Latin America Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 391: Rest of Latin America 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 392: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 393: Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 394: Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 395: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 396: Middle East Historic Review for Veterinary Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 397: Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 398: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 399: Middle East Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 400: Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 401: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 402: Middle East Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 403: Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 404: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 405: Middle East Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 406: Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 407: Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 408: Middle East Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 409: Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 410: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 411: Iran Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 412: Iran 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 413: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 414: Iran Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 415: Iran 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 416: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 417: Iran Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 418: Iran 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 419: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 420: Iran Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 421: Iran 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 422: Iran Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 423: Iran Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 424: Iran 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 425: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 426: Israel Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 427: Israel 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 428: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 429: Israel Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 430: Israel 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 431: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 432: Israel Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 433: Israel 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 434: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 435: Israel Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 436: Israel 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 437: Israel Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 438: Israel Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 439: Israel 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 440: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 441: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 442: Saudi Arabia 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 443: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 444: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 445: Saudi Arabia 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 447: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 448: Saudi Arabia 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 450: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 451: Saudi Arabia 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 453: Saudi Arabia Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 454: Saudi Arabia 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 455: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 456: UAE Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 457: UAE 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 458: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 459: UAE Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 460: UAE 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 461: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 462: UAE Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 463: UAE 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 464: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 465: UAE Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 466: UAE 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 467: UAE Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 468: UAE Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 469: UAE 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 470: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 471: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 472: Rest of Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 473: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 474: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 475: Rest of Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 477: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 478: Rest of Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 480: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 481: Rest of Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 483: Rest of Middle East Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 484: Rest of Middle East 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032
• AFRICA
  • Veterinary Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 485: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 486: Africa Historic Review for Veterinary Molecular Diagnostics by End-Use - Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 487: Africa 13-Year Perspective for Veterinary Molecular Diagnostics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • TABLE 488: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 489: Africa Historic Review for Veterinary Molecular Diagnostics by Offering - Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 490: Africa 13-Year Perspective for Veterinary Molecular Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Test Kits & Reagents Offering and Software & Services Offering for the Years 2020, 2026 & 2032
  • TABLE 491: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 492: Africa Historic Review for Veterinary Molecular Diagnostics by Animal Type - Companion Animal Type and Livestock Animal Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 493: Africa 13-Year Perspective for Veterinary Molecular Diagnostics by Animal Type - Percentage Breakdown of Value Sales for Companion Animal Type and Livestock Animal Type for the Years 2020, 2026 & 2032
  • TABLE 494: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 495: Africa Historic Review for Veterinary Molecular Diagnostics by Technology - PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 496: Africa 13-Year Perspective for Veterinary Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR Technology, DNA Sequencing Technology, Microarrays Technology and INAAT Kits Technology for the Years 2020, 2026 & 2032
  • TABLE 497: Africa Recent Past, Current & Future Analysis for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 498: Africa Historic Review for Veterinary Molecular Diagnostics by Application - Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 499: Africa 13-Year Perspective for Veterinary Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases Application, Metabolic Disease Application, Genetics Application and Other Applications for the Years 2020, 2026 & 2032

IV. COMPETITION